Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1917 1
1918 1
1942 1
1945 1
1946 4
1947 1
1948 1
1949 3
1952 3
1954 2
1955 2
1956 1
1957 1
1958 5
1959 4
1960 3
1961 5
1962 7
1963 9
1964 9
1965 5
1966 10
1967 3
1968 10
1969 12
1970 18
1971 15
1972 13
1973 9
1974 11
1975 15
1976 23
1977 19
1978 20
1979 19
1980 21
1981 29
1982 32
1983 14
1984 30
1985 20
1986 32
1987 52
1988 53
1989 46
1990 77
1991 90
1992 102
1993 95
1994 142
1995 157
1996 179
1997 221
1998 265
1999 328
2000 446
2001 548
2002 647
2003 739
2004 944
2005 1103
2006 1282
2007 1566
2008 1863
2009 2059
2010 2540
2011 2999
2012 3360
2013 3599
2014 3873
2015 4218
2016 4338
2017 4381
2018 4542
2019 4857
2020 5385
2021 5855
2022 5482
2023 5354
2024 5443
2025 3110

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

73,578 results

Results by year

Filters applied: . Clear all
Page 1
Nivolumab plus ipilimumab versus lenvatinib or sorafenib as first-line treatment for unresectable hepatocellular carcinoma (CheckMate 9DW): an open-label, randomised, phase 3 trial.
Yau T, Galle PR, Decaens T, Sangro B, Qin S, da Fonseca LG, Karachiwala H, Blanc JF, Park JW, Gane E, Pinter M, Peña AM, Ikeda M, Tai D, Santoro A, Pizarro G, Chiu CF, Schenker M, He A, Chon HJ, Wojcik-Tomaszewska J, Verset G, Wang QQ, Stromko C, Neely J, Singh P, Jimenez Exposito MJ, Kudo M; CheckMate 9DW investigators. Yau T, et al. Among authors: park jw. Lancet. 2025 May 24;405(10492):1851-1864. doi: 10.1016/S0140-6736(25)00403-9. Epub 2025 May 8. Lancet. 2025. PMID: 40349714 Free article. Clinical Trial.
Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma.
Bi K, He MX, Bakouny Z, Kanodia A, Napolitano S, Wu J, Grimaldi G, Braun DA, Cuoco MS, Mayorga A, DelloStritto L, Bouchard G, Steinharter J, Tewari AK, Vokes NI, Shannon E, Sun M, Park J, Chang SL, McGregor BA, Haq R, Denize T, Signoretti S, Guerriero JL, Vigneau S, Rozenblatt-Rosen O, Rotem A, Regev A, Choueiri TK, Van Allen EM. Bi K, et al. Among authors: park j. Cancer Cell. 2025 Jun 9;43(6):1177-1179. doi: 10.1016/j.ccell.2025.05.009. Cancer Cell. 2025. PMID: 40494276 Free PMC article. No abstract available.
Microbial dysbiosis fuels STING-driven autoinflammation through cyclic dinucleotides.
Shibahara T, Temizoz B, Egashira S, Hosomi K, Park J, Surucu N, Björk A, Sag E, Doi T, Kisla Ekinci RM, Balci S, Versnel MA, Kunisawa J, Yamamoto M, Hayashi T, Ito S, Kamiyama Y, Kobiyama K, Katsikis PD, Coban C, Gursel M, Ozen S, Nishida S, Kumanogoh A, Ishii KJ. Shibahara T, et al. Among authors: park j. J Autoimmun. 2025 Jun;154:103434. doi: 10.1016/j.jaut.2025.103434. Epub 2025 May 6. J Autoimmun. 2025. PMID: 40334619 Free article.
Droplet acoustofluidics: Recent progress and challenges.
Ali M, Kim W, Khan MS, Sahin MA, Destgeer G, Park J. Ali M, et al. Among authors: park j. Biomicrofluidics. 2025 Jun 4;19(3):031502. doi: 10.1063/5.0261531. eCollection 2025 May. Biomicrofluidics. 2025. PMID: 40488124 Review.
Intracerebroventricular bivalent CAR T cells targeting EGFR and IL-13Rα2 in recurrent glioblastoma: a phase 1 trial.
Bagley SJ, Desai AS, Fraietta JA, Silverbush D, Chafamo D, Freeburg NF, Gopikrishna GK, Rech AJ, Nabavizadeh A, Bagley LJ, Park J, Jarocha D, Martins R, Sarmiento N, Maloney E, Lledo L, Stein C, Marshall A, Leskowitz RM, Jadlowsky JK, Mackey S, Christensen S, Oner BS, Plesa G, Brennan A, Gonzalez V, Chen F, Barrett D, Colbourn R, Nasrallah MP, Mourelatos Z, Hwang WT, Alanio C, Siegel DL, June CH, Hexner EO, Binder ZA, O'Rourke DM. Bagley SJ, et al. Among authors: park j. Nat Med. 2025 Jun 1. doi: 10.1038/s41591-025-03745-0. Online ahead of print. Nat Med. 2025. PMID: 40451950
AAV for ovarian cancer gene therapy.
Yoo HC, Lee S, Park JY, Lee EJ. Yoo HC, et al. Among authors: park jy. Cancer Gene Ther. 2025 Jun 20. doi: 10.1038/s41417-025-00926-4. Online ahead of print. Cancer Gene Ther. 2025. PMID: 40542144 Review.
FDA-approved phensuximide inhibits RIPK1-dependent immunogenic cell death.
Kim BJ, Hong SM, Noh HJ, Kim J, Seon SY, Lee JE, Jeong DH, Park JM, Park S, Lee S, Kang J, Lee D, Morgan MJ, Kim YS. Kim BJ, et al. Among authors: park jm. Cell Death Dis. 2025 Jun 2;16(1):426. doi: 10.1038/s41419-025-07754-2. Cell Death Dis. 2025. PMID: 40456737 Free PMC article.
Accelerating Drug Development for Neuroblastoma: Consensus Statement From the Third Neuroblastoma Drug Development Strategy Forum.
DuBois SG, Moreno L, Anderson J, Asgharzadeh S, Bagatell R, Beck-Popovic M, Belle J, Berlanga P, Bird NJ, Chesler L, Durbin A, Eggert A, Eilers M, Federico SM, Fischer M, Gatz SA, George RE, George S, Goldsmith KC, Gray J, Heczey A, Irwin MS, Knox L, Lode HN, Ludwinski D, Macy ME, Majzner RG, Maris JM, Modak S, Molenaar JJ, Morgenstern DA, Mossé YP, Owens C, Reynolds CP, Rossig C, Schleiermacher G, Scott L, Sondel PM, Speleman F, van Noesel M, Westermann F, Wienke J, Wolpaw AJ, Park JR, Pearson ADJ. DuBois SG, et al. Among authors: park jr. Pediatr Blood Cancer. 2025 Jun 12:e31831. doi: 10.1002/pbc.31831. Online ahead of print. Pediatr Blood Cancer. 2025. PMID: 40509548 Review.
73,578 results
You have reached the last available page of results. Please see the User Guide for more information.